Lobar or sub-lobar resection for peripheral clinical stage IA ≤2 cm non-small cell lung cancer (NSCLC): Results from an international randomized phase III trial (CALGB 140503 [Alliance])
- Citation:
- J Thoracic Oncol vol 17 (Supplt 9) S1-S-2
- Meeting Instance:
- IASLC (WCLC) 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- collection
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3843
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Covidien/Tyco/Ethicon
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Nasser K Altorki Xiaofei Wang David Kozono Colleen Watt Rodney Landreneau Dennis Wigle Jeffrey Port David R Jones Robert Keenan Thomas Bauer Leslie J Kohman Thomas Stinchcombe Everett Vokes
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-NY016, NJ022, NY018, NY141, PA018
- Study
- CALGB-140503
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: